Table: Sapporo Clinical Lab -6-MTH group results
Nov 10 (Reuters)-
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2015 Sep 30, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.60 8.30 17.71
(+3.6 pct) (+1.6 pct) (+3.2 pct)
Operating 501 mln 378 mln 834 mln
(+32.5 pct) (-15.5 pct) (-4.0 pct)
Recurring 511 mln 394 mln 835 mln
(+29.8 pct) (-15.0 pct) (-6.8 pct)
Net 320 mln 235 mln 532 mln
(+36.3 pct) (-13.4 pct) (-7.1 pct)
EPS 92.04 yen 59.06 yen 153.15 yen
Ann Div 12.00 yen 11.00 yen
-Q2 div NIL NIL
-Q4 div 12.00 yen 11.00 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results